Ahmed, H. et al. 2026. Comparative Outcomes of Glucagon-Like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Cirrhosis. ASIDE Gastroenterology. 2, 4 (Jul. 2026), 1–7. DOI:https://doi.org/10.71079/ASIDE.GI.072726751.